Development and Validation of a Nomogram Model for Prognostic Assessment in Primary Cervical Squamous Cell Carcinoma with Serum SCC Antigen Levels ≥10 ng/mL Using Inflammatory Biomarkers and Clinical Variables - Top-Institutions - MDSpire

Development and Validation of a Nomogram Model for Prognostic Assessment in Primary Cervical Squamous Cell Carcinoma with Serum SCC Antigen Levels ≥10 ng/mL Using Inflammatory Biomarkers and Clinical Variables

  • By

  • Yiwei Zhao

  • Chutong Zhao

  • Yujie Liu

  • Yuan Wang

  • Yunyan Zhang

  • Sijia Liu

  • March 7, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Biomarkers
    • Inflammation and Cancer
  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Prognostics
    • Immuno-oncology
  • #3

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Biomarkers
    • Translational Oncology
  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Immunology
    • Biomarker Research

Original Source(s)

Related Content